Pharmacy |
| ||
|
Apo Oxybutynin Syrup Ditropan |
|
| ||
Home » Prescription Drugs 2 » Apo Oxybutynin Syrup Ditropan IndicationsOxybutynin chloride is primarily indicated for the management of urgency and incontinence that characterise neurogenic bladder disorders and idiopathic detrusor instabilityDosage and AdministrationAPO-OXYBUTYNIN is not recommended for children under 5 years.Pre-treatment examination should include cystometry and other appropriate diagnostic procedures. Cystometry should be repeated at appropriate intervals to evaluate response to therapy. Appropriate antimicrobial therapy should be instituted in the presence of infectionAdults:The usual dosage is 5mg taken 2 to 3 times daily. The maximum recommended dose is 5mg taken 4 times daily.Elderly patients:Initially treatment should be 2.5mg taken 2 times daily and increased as necessary.Children over 5 years:The usual dosage is 5mg taken twice daily. The maximum recommended dose is 5mg taken 3 times daily. Buy Apo Oxybutynin Syrup Ditropan and other Prescription Drugs 2 products online at Medstore. 5563
About Apo Oxybutynin Syrup Ditropan: Product Type: Prescription Drugs 2 Apo-Oxybutynin Syrup ( Ditropan Generic Oxybutynin ) Apo-Oxybutynin Syrup (Ditropan Generic Oxybutynin) Ditropan Generic Oxybutynin 5mg/5mL 473mL Ditropan Generic Oxybutynin Apo-Oxybutynin Syrup
View more Prescription Drugs 2 Pharmacy: Dozens of patents for name-brand drugs are due to expire within the next 14 months, and generic drugs will replace some of the most popular and widely advertised drugs used today. For millions of people worldwide, this means switching from familiar brands like Lipitor to generic equivalents. How will this affect drug companies, and what will be the impact on people who depend on expensive prescription medication? Here, a brief guide: Which drugs are scheduled to go generic? Some real blockbusters. "In the next two years, six of the 10 top-selling drugs will lose their patents," says Chris Woolston in the Los Angeles Times. Lipitor, the world's best-selling drug, which is used to lower cholesterol, will be available as a generic in November of this year. Another best-seller, the blood thinner Plavix, will lose its patent in May 2012. Other well-known drugs with expiring patents include the arthritis treatment Enbrel, the anti-psychotic Zyprexa, as well as drugs for bipolar disorder, HIV, high cholesterol, and other conditions.
| ||
